-
NeuroNEXT Clinical Trials (U01 Clinical Trial Optional)
(PAR-21-223)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Multiple dates, see announcement.
-
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
(PAR-21-224)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply
*** Note new SBIR/STTR Standard Due Dates.
-
NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed)
(PAR-21-228)
National Institute of Mental Health
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed)
(PAR-21-229)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): Multiple dates, see announcement.
-
NINDS Exploratory Clinical Trials (U01 - Clinical Trial Required)
(PAR-21-236)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Multiple dates, see announcement.
-
Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed)
(PAR-21-238)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): Not Applicable
-
Consortium for Innovative HIV/AIDS Vaccine and Cure Research (UM1 Clinical Trial Not Allowed)
(RFA-AI-21-039)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Not Applicable
-
Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U01 Clinical Trial Required)
(RFA-CA-21-031)
National Cancer Institute
Application Receipt Date(s): July 14, 2021
-
Coordinating Center for Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U24 Clinical Trial Not Allowed)
(RFA-CA-21-032)
National Cancer Institute
Application Receipt Date(s): July 14, 2021
-
Standardization of C-Peptide and HbA1C Measurements Program (U01 Clinical Trial Not Allowed)
(RFA-DK-21-007)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): October 20, 2021
-
Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 Clinical Trial Not Allowed)
(RFA-DK-21-011)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): March 9, 2022 and October 7, 2022
-
Integrated Pathogen Reduction Technologies for whole blood and blood components for transfusion (R01) Clinical Trials Not Allowed
(RFA-FD-21-032)
Food and Drug Administration
Application Receipt Date(s): July 6, 2021 by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
Human Milk as a Biological System (R01 Clinical Trial Optional)
(RFA-HD-22-020)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): November 29, 2021
-
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
(RFA-HL-23-004)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
(RFA-HL-23-005)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Research Program Award (R35 Clinical Trial Optional)
(RFA-NS-21-020)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): July 13, 2021
-
BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
(RFA-NS-21-023)
National Institute of Neurological Disorders and Stroke
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): Multiple dates, see announcement.
-
BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
(RFA-NS-21-024)
National Institute of Neurological Disorders and Stroke
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): Multiple dates, see announcement.